Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reviewing the Potential of Psychedelics for the Treatment of PTSD
Erwin Krediet, Tijmen Bostoen, Joost J. Breeksema, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 23, Iss. 6, pp. 385-400
Open Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
Danilo De Gregorio, Argel Aguilar‐Valles, Katrin H. Preller, et al.
Journal of Neuroscience (2020) Vol. 41, Iss. 5, pp. 891-900
Open Access | Times Cited: 185
Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, et al.
CNS Drugs (2020) Vol. 34, Iss. 9, pp. 925-946
Open Access | Times Cited: 166
The Therapeutic Potential of Psilocybin
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2948-2948
Open Access | Times Cited: 153
Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review
Nina Schimmers, Joost J. Breeksema, Sanne Y. Smith-Apeldoorn, et al.
Psychopharmacology (2021) Vol. 239, Iss. 1, pp. 15-33
Closed Access | Times Cited: 111
Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review
Lisa Burback, Suzette Brémault‐Phillips, Mirjam J. Nijdam, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 4, pp. 557-635
Closed Access | Times Cited: 94
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis
Kwonmok Ko, Emma I Kopra, Anthony J. Cleare, et al.
Journal of Affective Disorders (2022) Vol. 322, pp. 194-204
Closed Access | Times Cited: 84
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 15
Psilocybin and MDMA for the treatment of trauma-related psychopathology
Catherine Bird, Nadav Liam Modlin, James Rucker
International Review of Psychiatry (2021) Vol. 33, Iss. 3, pp. 229-249
Open Access | Times Cited: 63
Psychedelics and health behaviour change
Pedro J. Teixeira, Matthew W. Johnson, Christopher Timmermann, et al.
Journal of Psychopharmacology (2021) Vol. 36, Iss. 1, pp. 12-19
Open Access | Times Cited: 59
Ketamine and its metabolites: Potential as novel treatments for depression
Kai Zhang, Yitan Yao, Kenji Hashimoto
Neuropharmacology (2022) Vol. 222, pp. 109305-109305
Closed Access | Times Cited: 57
The Need for Psychedelic-Assisted Therapy in the Black Community and the Burdens of Its Provision
Darron T. Smith, Sonya C. Faber, NiCole T. Buchanan, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 43
Utility of 7,8-dihydroxyflavone in preventing astrocytic and synaptic deficits in the hippocampus elicited by PTSD
Juan Wang, Feng Gao, Shuai Cui, et al.
Pharmacological Research (2022) Vol. 176, pp. 106079-106079
Closed Access | Times Cited: 42
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
Emma I Kopra, Jason Ferris, Adam Winstock, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 733-748
Open Access | Times Cited: 33
Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity
Yingjie Du, Yunfeng Li, Xiangting Zhao, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 31
Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder
Jolien K. E. Veraart, M. van Westenbrugge, J.E. van Wulfften Palthe, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15883-e15883
Open Access | Times Cited: 25
Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential
Josh Allen, Shannon Dames, Claire J. Foldi, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 3, pp. 671-685
Closed Access | Times Cited: 13
Neuroimaging of posttraumatic stress disorder in adults and youth: progress over the last decade on three leading questions of the field
Cecilia A. Hinojosa, Grace George, Ziv Ben‐Zion
Molecular Psychiatry (2024) Vol. 29, Iss. 10, pp. 3223-3244
Open Access | Times Cited: 9
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders
Urszula Kozłowska, Charles D. Nichols, Kalina Wiatr, et al.
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 89-108
Open Access | Times Cited: 51
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 50
Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice
Błażej D. Pędzich, Sarah Rubens, Mehdi Sekssaoui, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 7, pp. 1304-1314
Open Access | Times Cited: 33
LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility
Isabel Wießner, Rodolfo Olivieri, Marcelo Falchi, et al.
European Neuropsychopharmacology (2022) Vol. 58, pp. 7-19
Closed Access | Times Cited: 32
Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications
Orr Shahar, Alexander Botvinnik, Noam Esh-Zuntz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14148-14148
Open Access | Times Cited: 31
Involvement of the brain–heart axis in the link between PTSD and cardiovascular disease
Antonia V. Seligowski, Theresa K. Webber, Paul J. Marvar, et al.
Depression and Anxiety (2022) Vol. 39, Iss. 10-11, pp. 663-674
Open Access | Times Cited: 30
Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms
Abigail E. Calder, Seline Mock, Nicole Friedli, et al.
European Neuropsychopharmacology (2023) Vol. 75, pp. 1-14
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top